Literature DB >> 3932304

Evolution and present situation of Staphylococcus aureus sensitivity to MLS in hospital (1975-83).

A Thabaut, M Meyran, M Huerre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3932304     DOI： 10.1093/jac/16.suppl_a.205

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

Review 1.  Formulary management of macrolide antibiotics.

Authors:  D R Guay
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

2.  In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.

Authors:  R Garcia; I Raad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

3.  Naturally occurring Staphylococcus epidermidis plasmid expressing constitutive macrolide-lincosamide-streptogramin B resistance contains a deleted attenuator.

Authors:  B C Lampson; J T Parisi
Journal:  J Bacteriol       Date:  1986-05       Impact factor: 3.490

Review 4.  Antimicrobial resistance of Staphylococcus aureus: genetic basis.

Authors:  B R Lyon; R Skurray
Journal:  Microbiol Rev       Date:  1987-03

Review 5.  Macrolide antibiotics in paediatric infectious diseases.

Authors:  D R Guay
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

6.  Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.

Authors:  J P Maskell; A M Sefton; J Yong; S J Chi; J D Williams
Journal:  Infection       Date:  1988       Impact factor: 3.553
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.